On Monday, June 29, Gilead announced the pricing of remdesivir, an anti-viral drug that treats COVID-19. The Coalition supports protecting consumers from unaffordable drug costs. The pricing decision will exacerbate the health care affordability crisis already plaguing the country’s response to COVID-19. Fundamentally, the United States needs to develop a fair drug pricing system that […]
On Monday, June 29, the House passed the Patient Protection and Affordable Care Enhancement Act (H.R. 1425). The Coalition supports protecting consumers from unaffordable health care costs in the individual market and creating overdue incentives for more states to expand Medicaid coverage. Read the Coalition’s statement on the bill here.
On June 15, NCHC’s John Rother collaborated with Katy Spangler, the Co-Director of Smarter Health Care Coalition, and Dr. A. Mark Fendrick, the Director of the University of Michigan Center for Value-Based Insurance Design, to publish an article in The Hill about high-value care amidst COVID-19. COVID-19 has created unprecedented opportunities for change, including the […]
On April 6, 2020, the National Coalition on Health Care (NCHC) sent a letter to Congress with policy recommendations for the fourth federal response to COVID-19. The recommendations were guided by NCHC’s diverse membership of health care, employer, and consumer leaders. While NCHC applauds Congress’ swift action on the first three legislative efforts in response […]
On Wednesday, March 25, the National Coalition on Health Care distributed a memo to summarize the provisions included in the 500+ pages of legislative text of the Coronavirus Aid, Relief, and Economic Security (CARES) Act, H.R. 748. […]